Judo Bio Secures $100M Financing to Advance Kidney-Targeted Oligonucleotide Medicines
Key Highlights Judo Bio secures $100M in initial financing for kidney-targeted medicines. Series A co-led by Atlas Venture, TCG, and…
Browsing Tag
Euclidean Capital
5 posts
Nura Bio Secures $140M in Series A Financing and Appoints Shilpa Sambashivan, Ph.D., as CEO
Key Highlights Nura Bio closes $140M Series A financing to support clinical development. Shilpa Sambashivan, Ph.D., appointed as CEO following…
Circle Pharma Closes $90 Million Series D Financing to Advance Clinical Pipeline
Key Highlights Circle Pharma raises $90 million in Series D funding led by The Column Group. Funding to support…
Kenai Therapeutics Secures $82M in Series A Funding
Key Highlights $82 million Series A funding co-led by prestigious investors to fuel Kenai’s innovative approach to neurodegenerative diseases.…
Actio Biosciences Secures $55 Million in Series A Financing to Advance Precision Medicine Therapeutics
Actio Biosciences, a biotech firm focusing on genetics and precision medicine, has successfully raised $55 million in a…